Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
888 participants
OBSERVATIONAL
2019-09-17
2021-11-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Describing practices in general medicine could help prioritize the relevance of clinical and ECG signs for the general practitioner, enabling to adjust the reading given the context.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluating Electrocardiogram (ECG) Abnormalities From Young Adulthood Through Middle Age
NCT00556751
The Signal-averaged ElectrocArdiogram in Long Term Follow-up of Chronic CHagas Disease - RIO de Janeiro Cohort
NCT01340963
Genetic and Phenotypic Characteristics of Mitral Valve Prolapse
NCT03884426
The Electronic Cardiovascular Genetics (eCG) Clinic for Presymptomatic Genetic Counselling
NCT06431425
"Incidence and Consequences of Disorders of Glycosylation in Patients With Conotruncal and Septal Heart Defects"
NCT02503267
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patient with indication of ElectroCardioGram (ECG)
Patient with indication of ElectroCardioGram (ECG) will be included. They will have a collection of results ElectroCardioGram (ECG).
ElectroCardioGram (ECG)
Collection of results ElectroCardioGram (ECG).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ElectroCardioGram (ECG)
Collection of results ElectroCardioGram (ECG).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* In doctor's office or at home, scheduled or not,
* During normal surgery hours or out-of-hours service,
* Whatever the reason for consultation,
* Aged 18 years or older,
* Having an indication of ElectroCardioGram (ECG) and/or request certificate of non-contra-indication to the practice of physical activity certificate of non-contra-indication to the practice of physical activity
Exclusion Criteria
* Patient with cognitive impairment who cannot give consent to participate in the study and / or patient under guardianship
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Association CNGE IRMG
UNKNOWN
Centre Hospitalier Universitaire de Saint Etienne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Paul FRAPPE, MD
Role: PRINCIPAL_INVESTIGATOR
CHU DE SAINT-ETIENNE
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Association CNGE IRMG
Saint-Etienne, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRBN432019/CHUSTE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.